Literature DB >> 2429148

Procedures for studying binding of interferon to human cells in suspension cultures.

J A Langer, S Pestka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2429148     DOI： 10.1016/0076-6879(86)19046-x

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  6 in total

1.  Creation of phosphorylation sites in proteins: construction of a phosphorylatable human interferon alpha.

Authors:  B L Li; J A Langer; B Schwartz; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Effect of interferon on Vero cells persistently infected with Sendai virus compared to Vero cells persistently infected with SSPE virus.

Authors:  M Crespi; M N Chiu; J K Struthers; B D Schoub; S F Lyons
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Radiation inactivation of human gamma-interferon: cellular activation requires two dimers.

Authors:  J A Langer; A Rashidbaigi; G Garotta; E Kempner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

4.  Tumor necrosis factor alpha modifies resistance to interferon alpha in vivo: first clinical data.

Authors:  T Moritz; O Kloke; M Nagel-Hiemke; G Kummer; U B Wandl; B Opalka; B Plappert; J Kempeni; S Seeber; N Niederle
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

5.  Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities.

Authors:  P S Subramaniam; S A Khan; C H Pontzer; H M Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

6.  Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.

Authors:  A X Delcayre; F Salas; S Mathur; K Kovats; M Lotz; W Lernhardt
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.